EDAP TMS reported EUR16.04M in Sales Revenues for its fiscal quarter ending in June of 2025.





Sales Change Date
AngioDynamics USD 72M 841K Feb/2025
Boston Scientific USD 5.29B 220M Dec/2025
EDAP TMS EUR 16.04M 2.48M Jun/2025
Henry Schein USD 3.4B 60M Dec/2025
Medtronic USD 9B 39M Jan/2026
Plus Therapeutics USD 1.31M 73K Dec/2023
Veracyte USD 140.6M 8.7M Dec/2025